From what 0 stock analysts predict, the share price for (BLUA) might decrease by NAN% in the next year. This is based on a 12-month average estimation for BLUA. Price targets go from $ to $. The majority of stock analysts believe BLUA is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assigned BLUA 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BLUA. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of BLUA.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Data Not Found! |
In 2023, BLUA generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that BLUA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - NYSE American has suspended trading of BlueRiver Acquisition Corp.'s Class A shares (BLUA) and units (BLUA.U) following a decision to delist all of the company's securities.
Why It Matters - The suspension and potential delisting of BlueRiver Acquisition Corp. shares signal financial instability, impacting investor confidence and liquidity in the stock.
Summary - NYSE American has suspended trading of BlueRiver Acquisition Corp.'s redeemable warrants (BLUA WS) following a prior decision to delist all of the company's securities.
Why It Matters - Suspension of trading in BlueRiver Acquisition's warrants signals regulatory concerns, likely affecting investor confidence and liquidity, potentially leading to price volatility for related securities.
Summary - BlueRiver Acquisition Corp. (BLUA) may face delisting from NYSE American as the exchange initiated proceedings following a notification received on February 2, 2024.
Why It Matters - The delisting proceedings by NYSE American could lead to reduced liquidity and investor confidence, potentially driving down BlueRiver Acquisition Corp.'s stock price.
Summary - NYSE American has initiated delisting proceedings for BlueRiver Acquisition Corp.'s Class A shares (BLUA) and units (BLUA.U) due to regulatory decisions.
Why It Matters - Delisting signals financial distress or compliance issues, potentially leading to decreased investor confidence and liquidity concerns for BlueRiver Acquisition Corp. securities.
Summary - Spinal Stabilization Technologies and BlueRiver Acquisition Corp. have agreed to a business combination. The new entity will operate as Spinal Stabilization Technologies and be publicly listed.
Why It Matters - The merger could enhance SST's market visibility and access to capital through BlueRiver, potentially increasing shareholder value and attracting investor interest in the combined entity.
Summary - BlueRiver Acquisition Corp. (NYSE: BLUA) has received approval to transfer its listing from the NYSE to NYSE American, effective March 21, 2023.
Why It Matters - BlueRiver's transfer to NYSE American may indicate a shift in market perception, potentially affecting liquidity and investor confidence, impacting share performance and valuation.